Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Topiramate NDC 70518-3460 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Topiramate is a medication that comes in the form of a 50mg tablet. There are 30 tablets in each box. The medication is only available with a prescription. The NDC number for the medication is 70518-3460-00 and it expires at an unspecified date. It was repackaged by RemedyRepack inc. and the manufacturer of the medication is Rising Pharma based in Allendale, NJ. It is important to keep the medication out of the reach of children and it should be stored at a temperature range of 20-25°C (88-77°F), with some permissible excursions (15-30°C or 59-86°F). Directions for use are provided in the package insert.*

MM2 - Topiramate 50mg 70518 3460 01

MM2 - Topiramate  50mg 70518 3460 01

Topiramate is a tablet with a strength of 50mg, in a quantity of 1. The medication's packaging is labeled with the brand name "Reme Orepack" and the prescription information "RX ONLY". The medication is listed with the National Drug Code (NDC) number 70518-3460-01 and the manufacturer is Rising Pharma, Inc., located in Allendale, NJ. The medication should be stored at a temperature between 20-25°C (88-77°F) with possible excursions permitted between 15-30°C (59-86°F). Despite being repackaged by RemedyRepack Inc. in Indiana, PA, the medication should still be kept out of the reach of children. Directions for the use of this medication can be found in the Package Insert.*

Figure 1: Kaplan-Meier Estimates of Cumulative Rates for Time to First Seizure - topiramate fig1

Figure 1: Kaplan-Meier Estimates of Cumulative Rates for Time to First Seizure - topiramate fig1

This is a chart showing the cumulative rates for Time to First Seizure for individuals taking either Topiramate 50 mg/day (sample size of 234) or Topiramate 400 mo/day (sample size of 236) over the course of several days, up to 500. The x-axis shows the time in days, while the y-axis shows the dosage in mg/day.*

Figure 2 - topiramate fig2

Figure 2 - topiramate fig2

chemical structure - topiramate str

chemical structure - topiramate str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.